Li Tusheng, Jiang Qiang, Zhong Wei, Zhu Tengyue, Lu Zhengcao, Ding Yu
Orthopedics of TCM Senior Department, The Sixth Medical Center of PLA General Hospital, 6 Fucheng Road, Haidian District, Beijing, 100048, People's Republic of China.
The Second School of Clinical Medicine, Southern Medical University, Guangzhou, People's Republic of China.
J Orthop Surg Res. 2024 Apr 22;19(1):254. doi: 10.1186/s13018-024-04743-7.
The one-hole split endoscopy (OSE) was first proposed and clinically applied in China in 2019. The aim of this study was to compare the clinical efficacy of one-hole split endoscopy (OSE) and unilateral biportal endoscopy (UBE) for treating lumbar spinal stenosis (LSS).
One hundred sixty patients with LSS who met the inclusion from November 2020 to August 2022 were analyzed and divided into OSE and UBE groups. The propensity score matching (PSM) method was used to adjust the imbalanced confounding variables between the two groups. After matching, surgical outcomes were recorded, and clinical data, including functional scores and imaging findings, were compared. Functional scores included the visual analog scale of leg pain (VAS-LP) and back pain (VAS-BP), the Japanese Orthopedic Association score (JOA), and the Oswestry Disability Index (ODI). Imaging data included dural sac cross-sectional area (DCSA), lumbar range of motion (ROM), and sagittal translation (ST).
After PSM, 104 LSS patients were included in the study, and all covariates were well-balanced between the two groups. Among the matched patients, the OSE showed advantages over the UBE regarding operative time (62.42 ± 4.86 vs. 68.96 ± 4.56) and incision length (2.30 ± 0.14 vs. 2.70 ± 0.15) (P < 0.001). However, differences between the two groups in intraoperative blood loss, hospital length of stay, and complication rates were not statistically significant (P > 0.05). There was no statistically significant difference regarding VAS-BP, VAS-LP, JOA, and ODI between the two groups (P > 0.05). However, all clinical and functional scores significantly improved postoperatively (P < 0.05). Postoperative DCSA of both groups was significantly found to be improved (P < 0.05), ROM and ST remained within the normal range, and no cases of lumbar instability were recorded. According to the modified MacNab criteria, the excellent and good rates in the OSE and UBE groups were 94.23% and 90.38%, respectively, with no statistically significant difference (P = 0.713).
OSE is an alternative technique to UBE for the treatment of LSS, with similar satisfactory clinical outcomes, shorter operative time, and smaller incision length. Further studies are needed for long-term efficacy.
单孔分体式内镜(OSE)于2019年在中国首次提出并应用于临床。本研究旨在比较单孔分体式内镜(OSE)和单侧双通道内镜(UBE)治疗腰椎管狭窄症(LSS)的临床疗效。
分析2020年11月至2022年8月符合纳入标准的160例LSS患者,并将其分为OSE组和UBE组。采用倾向得分匹配(PSM)方法调整两组间不均衡的混杂变量。匹配后,记录手术结果,并比较包括功能评分和影像学表现在内的临床数据。功能评分包括腿痛视觉模拟量表(VAS-LP)和背痛视觉模拟量表(VAS-BP)、日本骨科协会评分(JOA)和Oswestry功能障碍指数(ODI)。影像学数据包括硬脊膜囊横截面积(DCSA)、腰椎活动度(ROM)和矢状面移位(ST)。
PSM后,104例LSS患者纳入研究,两组间所有协变量均达到良好平衡。在匹配患者中,OSE在手术时间(62.42±4.86对68.96±4.56)和切口长度(2.30±0.14对2.70±0.15)方面优于UBE(P<0.001)。然而,两组在术中出血量、住院时间和并发症发生率方面的差异无统计学意义(P>0.05)。两组间VAS-BP、VAS-LP、JOA和ODI差异无统计学意义(P>0.05)。然而,所有临床和功能评分术后均显著改善(P<0.05)。两组术后DCSA均显著改善(P<0.05),ROM和ST保持在正常范围内,未记录到腰椎不稳病例。根据改良MacNab标准,OSE组和UBE组的优良率分别为94.23%和90.38%,差异无统计学意义(P=0.713)。
OSE是治疗LSS的一种替代UBE的技术,临床效果相似,手术时间更短,切口长度更小。长期疗效还需要进一步研究。